Skip to main content
. 2021 Jan 16;13(1):111. doi: 10.3390/pharmaceutics13010111

Figure 4.

Figure 4

DSC (A), PXRD (B), and FTIR (C) curves of the MTX powder (a), Na-CMC (b), SLS (c), physical mixture (d), and F6 formulation (e).